Abstract

The present disclosure relates to a process for the preparation of pure Xanomeline of formula-1 and its pharmaceutically acceptable salts. The structure of the formula-1 is shown below:

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS